BioCentury
ARTICLE | Clinical News

Oral Campylobacter vaccine with mucosal adjuvant: ANTX began a Phase I/II trial in 100 volunteers

September 23, 1996 7:00 AM UTC

Antex Biologics (ANTX), Gaithersburg, Md. Product: Oral Campylobacter vaccine with mucosal adjuvant Indication: Prevent gastroenteritis and diarrhea Status: ANTX began a Phase I/II trial in 100 volunt...